The U.S. Court of Federal Claims has dismissed a patent infringement lawsuit brought by three companies that claim the Defense Department has been using their patented medical imaging invention without permission.
08 Jul 2013Catherine Tomasko
Judge Edward J. Damich said NeuroGrafix, Neurography Institute Medical Associates Inc. and Image-Based Surgicenter Corp. lack standing to pursue their suit against the government.
Our global conference coverage team is made up of scientific specialists and industry professionals. They understand you want comprehensive coverage and you want it now. Which is why we promise to deliver full reports within 28 days of a conference ending — but average 14. Be the first to act on the latest drug pipeline and patents information — with broad conference coverage from Cortellis for Competitive Intelligence.
Patents are really a proxy for innovation. Inventive ideas that are unprotected can’t be successfully commercialized. Therefore, by looking at patent activity, one gets a true picture of the innovative landscape, regardless of how commercially successful an invention is.
Pharma giant Merck & Co. is asking the U.S. Supreme Court to review a federal appeals court’s decision that payments by pharmaceutical companies to generic-drug manufacturers to delay the arrival of less expensive medicines should be viewed as evidence of an unlawful restraint of trade.
Decisions about patentability in cases before the Federal Circuit are based not on the merits of a patent but on which judges happen to hear the appeal, a group of scientists says in a petition to the U.S. Supreme Court.
29 Aug 2012Deborah Nathan
According to the professors at the Yale University School of Medicine and the University College London Medical School, the Supreme Court must resolve an internal conflict in the Federal Circuit that results in the appeals court’s inconsistent adherence to high court precedent. (more…)
Apple’s claims on infringements made by Samsung in their various mobile and tablet devices are categorized in three distinct groups: design, utility & trade dress. Today’s graphics provides some highlights for each of the three categories.
By tracking published patent applications, examining real-world trademark and copyright infringement issues and comparing the government policies and long-term innovation strategies of China to other world leaders, new reports from Thomson Reuters suggest that although China leads the world in patent and trademark filings, its status as a global player still faces challenges.
30 Dec 2011Thomson Reuters
“Intellectual property is the bridge that connects innovation with economic growth,” said David Brown, president of the IP Solutions business of Thomson Reuters. “We’ve taken on this research as a means of identifying the point where innovation and creativity meet marketability, thus setting the stage for sustained economic development. By closely examining a wide variety of metrics, we can see China is clearly on that path, but there are significant milestones yet to be attained.”
Among the key findings detailed in the free Thomson Reuters China reports on patent and trademark trends:
China Now Leads World in Patent Filings: Published patent applications in China increased by 16.7 percent between 2006 and 2010; and this year’s patent activity secures China’s status as the world leader in patent application volume, as previously predicted by Thomson Reuters. Thomson Reuters projects that China will publish 493,000 patent applications annually by 2015.
Trademark Applications Surge: Since 2000, the number of trademarks registered in China has increased by more than 450 percent, far outpacing other nations, despite widespread counterfeiting and infringement.
Growing Influence in Scientific Literature: Over the last five years, there has been an 80 percent increase in Chinese scientific literature annual output, making China second in the world in published scientific papers. The United States, which currently has the highest overall output, grew by five percent.
Slow to Expand Globally: Chinese organizations are not protecting their inventions by filing patents globally at the same level as other innovation-minded countries. Currently, only 5.6 percent of China’s inventions are protected with global patent filings abroad, far less than the United States (48.8 percent) and Japan (38.7 percent).
China’s Corporate Innovation Lags: According to the Thomson Reuters Top 100 Global Innovators analysis, the most innovative companies in the world are based in the United States (40 percent), Europe (29 percent) and Japan (27 percent).
Global Brands Capitalize on Chinese Consumerism: In an economic environment that is expected to reach $4.3 trillion USD in retail spending by 2015, leading multinational companies have been among the top 20 trademark filers in China from 1976 through 2011.
The research findings are available in two new reports from the IP Solutions business of Thomson Reuters. Invented in China assesses total patent volumes and highlights growing areas of innovation activity in China. Special Report: Trademarks in Chinatracks trends in trademark activity in China over the last 20 years and analyzes trademark activities of the world’s leading brands.